Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | F2 | P00734 | 3/20 | 0.58 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.58 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.58 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | EDNRA | P25101 | 10/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | NSD2 | O96028 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29763486 | 1.00 | CA2 (0.69) | CA2CYP1A2CYP2C19HTTHIF1A | |
| SCHEMBL30958757 | 0.98 | CA2 (0.67) | CA2CYP1A2CYP2C19HTTHIF1A | |
| SCHEMBL9019311 | 0.83 | CA2 (0.71) | CA2CYP1A2CYP2C19HTTHIF1A | |
| SCHEMBL1131010 | 0.83 | CA2 (0.71) | CA2CYP1A2CYP2C19HTTHIF1A | |
| SCHEMBL11508876 | 0.82 | ELANE (0.46) | CA2CYP1A2CYP2C19HTTHIF1A | |
| SCHEMBL21283 | 0.81 | CA2 (0.69) | CA2CYP1A2CYP2C19HTTHIF1A | |
| SCHEMBL108421 | 0.81 | CA2 (1.00) | CA2CYP1A2CYP2C19HTTHIF1A | |
| SCHEMBL11948494 | 0.81 | CA2 (0.69) | CA2CYP1A2CYP2C19HTTHIF1A | |
| SCHEMBL10730548 | 0.81 | CA2 (0.69) | CA2CYP1A2CYP2C19HTTHIF1A | |
| SCHEMBL133520 | 0.81 | CA2 (0.69) | CA2CYP1A2CYP2C19HTTHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1043 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117790902-A | Electrolyte containing sulfonyl fluoride compound and lithium ion battery containing electrolyte | 湖州昆仑亿恩科电池材料有限公司 | 2024-03-29 | — | — | CN | claimed |
| WO-2023164252-A1 | ISOTHERMAL NUCLEIC ACID DETECTION ASSAYS AND USES THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2023-08-31 | — | — | WO | claimed |
| US-10892522-B2 | Nonaqueous electrolytic solution and lithium secondary battery | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2021-01-12 | — | — | US | claimed |
| CN-109342381-A | A kind of fluorescent dyeing reagent | 广州往圣生物科技有限公司 | 2019-02-15 | — | — | CN | claimed |
| US-20180183101-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND LITHIUM SECONDARY BATTERY | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2018-06-28 | — | — | US | claimed |
| US-9915665-B2 | High-throughput system and method for identifying antibodies having specific antigen binding activities | ABBVIE INC. (US) | 2018-03-13 | — | — | US | claimed |
| EP-2938636-A2 | HIGH-THROUGHPUT SYSTEM AND METHOD FOR IDENTIFYING ANTIBODIES HAVING SPECIFIC ANTIGEN BINDING ACTIVITIES | AbbVie Inc. (US) | 2015-11-04 | — | — | EP | claimed |
| US-20140243228-A1 | HIGH-THROUGHPUT SYSTEM AND METHOD FOR IDENTIFYING ANTIBODIES HAVING SPECIFIC ANTIGEN BINDING ACTIVITIES | ABBVIE, INC. (US) | 2014-08-28 | — | — | US | claimed |
| WO-2014106004-A2 | HIGH-THROUGHPUT SYSTEM AND METHOD FOR IDENTIFYING ANTIBODIES HAVING SPECIFIC ANTIGEN BINDING ACTIVITIES | ABBVIE, INC. (US) | 2014-07-03 | — | — | WO | claimed |
| WO-2013070943-A2 | SMALL MOLECULE SCREEN FOR INHIBITORS OF NFAT:AP-1:DNA INTERACTIONS | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2013-05-16 | — | — | WO | claimed |
| WO-2009018368-A1 | COMBINATION TREATMENT OF NMDA (N-METHYL-D-ASPARTATE)-ENHANCER, GLYCINE TRANSPORTER INHIBITOR, D-AMINO ACID OXIDASE INHIBITOR (DAAOI) FOR NEUROPSYCHIATRIC DISORDERS | LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (US) | 2009-02-05 | — | — | WO | claimed |
| US-20080315084-A1 | ANALYSIS METHOD OF AMINO ACID USING MASS SPECTROMETER | AJINOMOTO CO. INC (JP) | 2008-12-25 | — | — | US | claimed |
| EP-1965205-A1 | AMINO ACID ANALYSIS METHOD USING MASS SPECTROMETER | Ajinomoto Co., Inc. (JP) | 2008-09-03 | — | — | EP | claimed |
| US-5302371-A | Fluorescent organosilicon compounds and methods | DOW CORNING CORPORATION (US) | 1994-04-12 | — | — | US | claimed |
| US-5110746-A | Method for the determination of albumin in biological fluids | PHARMACIA DIAGNOSTICS INC. (US) | 1992-05-05 | — | — | US | claimed |
| EP-0287745-B1 | METHOD FOR THE DETERMINATION OF ALBUMIN IN BIOLOGICAL FLUIDS | SCHIAPPARELLI BIOSYSTEMS, INC. (US) | 1991-11-13 | — | — | EP | claimed |
| WO-1988008533-A1 | METHOD FOR THE DETERMINATION OF ALBUMIN IN BIOLOGICAL FLUIDS | ELECTRO-NUCLEONICS, INC. (US) | 1988-11-03 | — | — | WO | claimed |
| EP-0287745-A1 | Method for the determination of albumin in biological fluids | SCHIAPPARELLI BIOSYSTEMS, INC. (US) | 1988-10-26 | — | — | EP | claimed |
| WO-2026107198-A1 | ANTIBODY BIOMARKER TO DIAGNOSE IDIOPATHIC INFLAMMATORY MYOPATHIES | OHIO STATE INNOVATION FOUNDATION (US) | 2026-05-21 | — | — | WO | disclosed |
| EP-0287745-A1 | Method for the determination of albumin in biological fluids | SCHIAPPARELLI BIOSYSTEMS, INC. (US) | 1988-10-26 | — | — | EP | disclosed |